quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
hematopoietic stem cell transplantation	718
of conflict of interest	479
disclosure of conflict of	479
allogeneic hematopoietic stem cell	379
allogeneic stem cell transplantation	351
at the time of	329
graft versus host disease	207
in the absence of	199
for the treatment of	189
of this study was	182
this study was to	176
in the presence of	171
the aim of this	166
with a median follow	156
hematopoietic stem cell transplant	149
in the setting of	146
autologous stem cell transplantation	144
in the treatment of	143
aim of this study	140
at a median of	128
peripheral blood stem cells	124
after allogeneic stem cell	121
median age was years	119
a total of patients	118
after allogeneic hematopoietic stem	117
in the united states	117
solid organ transplant recipients	115
as well as the	112
has been shown to	111
cd and cd t	110
in lung transplant recipients	108
peripheral blood stem cell	105
the cumulative incidence of	102
a median of days	99
allogeneic hematopoietic cell transplantation	97
stem cell transplant recipients	94
haematopoietic stem cell transplantation	94
stem cell transplantation in	93
median follow up of	92
a median age of	91
acute and chronic gvhd	90
is associated with a	89
was found to be	88
in the context of	86
in solid organ transplant	85
is one of the	84
with a median age	84
and cd t cells	84
a median follow up	83
after hematopoietic stem cell	82
is the most common	80
p disclosure of conflict	80
on the other hand	77
the median age was	77
specific cd t cells	76
the median time to	75
as a result of	75
the majority of patients	75
for the development of	75
after a median follow	75
in renal transplant recipients	75
there was no significant	74
a median time of	73
for the first time	73
has been associated with	73
there was no difference	72
no significant difference in	72
an important role in	71
cumulative incidence of relapse	69
been shown to be	69
nothing to declare background	68
were included in the	67
was associated with a	66
of cd t cells	65
of morbidity and mortality	65
in a patient with	64
median age of years	63
in the present study	62
in the pathogenesis of	62
to be associated with	61
the median number of	61
was no significant difference	61
safety and efficacy of	61
stem cell transplantation for	61
in the case of	60
this is the first	60
at the end of	60
severe acute respiratory syndrome	59
peripheral blood mononuclear cells	59
at a dose of	59
play a role in	59
after bone marrow transplantation	58
an increased risk of	58
in vitro and in	58
on the basis of	58
it is important to	58
study was to evaluate	58
in this study we	57
to the development of	57
with a history of	57
the median age at	57
in the majority of	57
one of the most	56
morbidity and mortality in	56
have been shown to	56
has been reported to	56
patients were treated with	56
a risk factor for	56
the median age of	55
for the diagnosis of	54
of the patients with	54
median time to neutrophil	54
of the immune system	54
were found to be	53
in of the patients	53
t cells in the	53
blood stem cell transplantation	53
was significantly higher in	53
vitro and in vivo	53
stem cell source was	52
nothing to declare p	52
in the era of	52
in the development of	51
of acute and chronic	51
of allogeneic hematopoietic stem	51
at the age of	51
acute graft versus host	51
in a cohort of	51
source of stem cells	51
at the same time	51
was to evaluate the	50
blood and marrow transplantation	50
associated with an increased	50
cause of morbidity and	50
our data suggest that	49
studies are needed to	49
of cd and cd	48
of hematopoietic stem cell	48
in hematopoietic stem cell	48
at months of age	48
between the two groups	48
play an important role	48
autologous hematopoietic stem cell	48
for the prevention of	48
stem cell transplantation is	47
and the use of	46
neutrophil and platelet engraftment	46
as part of the	46
the end of the	46
allogeneic stem cell transplant	46
the aim of the	45
number of cd cells	45
have been associated with	45
are shown in table	45
was no difference in	44
allogeneic bone marrow transplantation	44
little is known about	44
were included in this	44
in the course of	44
allogeneic haematopoietic stem cell	43
at a median follow	43
for the management of	43
a major cause of	43
cd t cells in	43
after stem cell transplantation	43
highly active antiretroviral therapy	43
of this study is	43
incidence of acute gvhd	42
the number of cd	42
most common cause of	42
a retrospective analysis of	42
was observed in patients	42
acute respiratory distress syndrome	42
with the development of	42
efficacy and safety of	42
with the use of	42
in addition to the	42
in the number of	42
there were no significant	42
haploidentical stem cell transplantation	42
we were able to	42
total of patients were	41
this study is to	41
in patients who received	41
the incidence of acute	41
bone marrow transplant recipients	41
the most common cause	41
as well as in	41
transplantation in patients with	40
the incidence of cmv	40
acute or chronic gvhd	40
the outcome of patients	40
time from diagnosis to	40
was found to have	40
the safety and efficacy	40
significantly higher in the	40
cd t cells were	40
our results suggest that	39
a significant increase in	39
diagnosis and management of	39
patients with hematological malignancies	39
with an increased risk	39
the purpose of this	39
there were no differences	39
mg kg kg tag	39
follow up of months	39
was significantly lower in	38
review of the literature	38
the objective of this	38
we performed a retrospective	38
with a median of	38
included in the study	38
the conditioning regimen was	38
been reported to be	38
in the general population	38
for the presence of	38
in the first months	38
gvhd prophylaxis consisted of	38
objective of this study	38
patients with multiple myeloma	38
option for patients with	37
was not associated with	37
at years of age	37
the median duration of	37
causes of death were	37
cd t cells and	37
should be considered in	37
patients with hiv infection	37
presence or absence of	36
with a median time	36
age at transplant was	36
the first year after	36
in patients with aids	36
on the use of	36
the intensive care unit	36
with acute myeloid leukemia	36
none of the patients	36
of the patients who	36
in allogeneic hematopoietic stem	36
median age of the	35
of the patients were	35
of human immunodeficiency virus	35
of the conditioning regimen	35
can be used to	35
in the peripheral blood	35
acute gvhd grade ii	35
after a median of	35
are summarized in table	35
in patients with acute	35
reduce the risk of	35
in patients with hiv	35
in the regulation of	34
on the outcome of	34
in the first year	34
dose of mg kg	34
in solid organ transplantation	34
these data suggest that	34
of allogeneic stem cell	34
year cumulative incidence of	34
the presence of a	34
of the study was	34
these results suggest that	34
for blood and marrow	34
in patients with severe	34
therapy in patients with	34
in the management of	34
is the only curative	33
and is associated with	33
patient and graft survival	33
at a median time	33
chronic graft versus host	33
of patients with a	33
of the immune response	33
have been reported in	33
median time of days	33
the stem cell source	33
patients who did not	33
patients with high risk	32
the time of the	32
the role of the	32
conditioning regimen consisted of	32
the presence of the	32
no significant differences in	32
median age at transplant	32
morbidity and mortality after	32
prevention and treatment of	32
there was a trend	32
the time of transplant	32
and the presence of	32
was to assess the	31
in heart transplant recipients	31
is associated with increased	31
in the bone marrow	31
we found that the	31
a cohort of patients	31
in the first days	31
t and b cells	31
during the first year	31
of the patients had	31
in the control group	31
patients with acute leukemia	31
the main cause of	31
associated with a higher	31
were no significant differences	31
purpose of this study	30
aim of the study	30
associated with increased risk	30
as a cause of	30
was significantly associated with	30
included in this study	30
as well as a	30
studies have shown that	30
it has been shown	30
a dose of mg	30
cause of death in	30
cd t cells from	30
may be associated with	29
with the exception of	29
conditioning regimen was myeloablative	29
in allogeneic stem cell	29
during the study period	29
cohort of patients with	29
incidence of chronic gvhd	29
of patients who received	29
patients with acute myeloid	29
in patients treated with	29
important role in the	29
human immunodeficiency virus type	29
the results of the	29
an important cause of	29
or in combination with	29
is thought to be	29
for the detection of	29
of the patients was	29
in patients with a	29
the presence or absence	29
the present study was	29
of the patients received	29
outcome of patients with	29
in the diagnosis of	29
significant morbidity and mortality	29
in the multivariate analysis	28
within the first year	28
a high rate of	28
at high risk for	28
was the most common	28
the treatment of choice	28
and the development of	28
infections in patients with	28
human immunodeficiency virus infection	28
at different time points	28
centers for disease control	28
significant difference in the	28
a member of the	28
national institutes of health	28
has been reported in	28
patients with a median	28
are the most common	28
the first months after	28
we conducted a retrospective	28
after solid organ transplantation	28
data with implanted signals	28
vg vd t cells	28
after allogeneic hematopoietic cell	28
a higher risk of	27
working party of the	27
and the risk of	27
were associated with a	27
study was to analyze	27
age of the patients	27
a role in the	27
was not statistically significant	27
the median time of	27
a matched unrelated donor	27
proportion of patients with	27
in patients with aml	27
disease control and prevention	27
were more likely to	27
for disease control and	27
source was peripheral blood	27
compared to healthy controls	27
evaluate the impact of	27
in the two groups	27
in any of the	26
between january and december	26
haploidentical hematopoietic stem cell	26
was observed in the	26
the only curative treatment	26
alone or in combination	26
a wide range of	26
the time of transplantation	26
to be effective in	26
infection in patients with	26
compared to patients with	26
as compared to the	26
in this retrospective study	26
by flow cytometry and	26
of hematopoietic stem cells	26
treatment of patients with	26
the median time from	26
was defined as the	26
there was a significant	26
within the first months	26
associated with a high	26
a large number of	26
treatment for patients with	26
the first year of	26
of cmv infection in	25
in human immunodeficiency virus	25
the proportion of patients	25
in patients with high	25
our results show that	25
cell transplantation in patients	25
has been shown that	25
and total body irradiation	25
and the number of	25
the majority of the	25
most of the patients	25
no conflict of interest	25
were no differences in	25
reduced intensity conditioning regimen	25
the course of the	25
and cd t cell	25
at high risk of	25
in pediatric patients with	25
the risk of developing	25
the first days after	25
de un trasplante de	25
in the group of	25
t and b cell	25
study was to determine	25
a significant proportion of	25
in bal fluid specimens	24
with increased risk of	24
patients with and without	24
in critically ill patients	24
plays an important role	24
heart and lung transplantation	24
had no effect on	24
to reduce the risk	24
stem cell transplantation from	24
the majority of cases	24
a reduced intensity conditioning	24
group and in the	24
x cd cells kg	24
cells as well as	24
has the potential to	24
after allogeneic bone marrow	24
of severe acute respiratory	24
of our study was	24
in the early post	24
for a median of	24
we have shown that	24
of patients who underwent	24
risk factors for the	24
within the first days	24
by the use of	24
during the course of	24
pneumocystis carinii pneumonia in	24
investigate the role of	24
patients were included in	24
to neutrophil and platelet	24
in more than of	24
incidence of cmv infection	24
is the most important	24
and autologous stem cell	24
did not differ between	24
further studies are needed	23
a matched related donor	23
in an attempt to	23
human immunodefi ciency virus	23
the development of a	23
be considered as a	23
source was bone marrow	23
similar in both groups	23
of acute gvhd grade	23
to be safe and	23
we retrospectively analyzed the	23
and hematopoietic stem cell	23
to the presence of	23
was not significantly different	23
the age of years	23
during the first days	23
the aim of our	23
patients with cmv reactivation	23
both cd and cd	23
the total number of	23
patients who received a	23
associated with the development	23
the study was to	23
of patients treated with	23
umbilical cord blood transplantation	23
patients died due to	23
in the last years	23
the central nervous system	23
median age at diagnosis	23
was significantly higher than	23
of the present study	23
median time from diagnosis	23
in liver transplant recipients	23
caused by mutations in	23
was associated with an	23
of cd cells in	23
results suggest that the	23
median age of patients	23
is a risk factor	23
those who did not	23
is known about the	23
reduce the incidence of	22
is associated with the	22
the risk of infection	22
during the first months	22
median follow up was	22
are involved in the	22
the case of a	22
was to investigate the	22
a large cohort of	22
the use of the	22
study was to assess	22
a significant reduction of	22
received peripheral blood stem	22
to investigate the role	22
more common in the	22
in the current study	22
high morbidity and mortality	22
in children and adults	22
the expression of the	22
in the incidence of	22
median age at hsct	22
to evaluate the impact	22
be involved in the	22
may contribute to the	22
was to analyze the	22
in out of patients	22
immune reconstitution inflammatory syndrome	22
than months of age	22
the lower respiratory tract	22
in organ transplant recipients	22
can be used as	22
in the form of	22
that the use of	22
were significantly higher in	22
the efficacy and safety	22
the risk factors for	22
study is to evaluate	22
a median number of	22
cd cd t cells	22
in a mouse model	22
study was to investigate	22
time to neutrophil engraftment	22
a high risk of	22
in contrast to the	22
stem cell transplantation with	22
the number of patients	22
may play a role	22
our aim was to	22
for hematopoietic stem cell	22
of the gastrointestinal tract	21
may be due to	21
a mouse model of	21
on behalf of the	21
survival in patients with	21
these data indicate that	21
of the study is	21
have been reported to	21
in a multivariate analysis	21
specific cd and cd	21
the diagnosis and management	21
the most commonly used	21
over a period of	21
this group of patients	21
was used as a	21
a significant reduction in	21
the natural history of	21
on the waiting list	21
therapy for patients with	21
statistical analysis was performed	21
our study was to	21
be considered in the	21
were in complete remission	21
in up to of	21
engraftment was achieved in	21
in a variety of	21
cd and cd cells	21
the time of hsct	21
the impact of the	21
group for blood and	21
with the presence of	21
one of the major	21
be used as a	21
an increase in the	21
in bone marrow transplant	21
more likely to have	21
has been observed in	21
patients who underwent allogeneic	21
in first complete remission	21
the risk of relapse	21
autologous peripheral blood stem	21
of regulatory t cells	21
as stem cell source	21
our results indicate that	21
as a consequence of	21
cumulative incidence of grade	21
infectious diseases society of	21
at increased risk for	21
the innate immune system	21
a median of months	21
no statistically significant difference	21
no significant difference between	21
the major cause of	21
iv acute gvhd was	21
in patients undergoing allogeneic	21
on the day of	21
median time to platelet	21
has also been reported	21
patients were transplanted in	21
a key role in	20
of minimal residual disease	20
a higher incidence of	20
in patients with primary	20
of respiratory syncytial virus	20
for the identification of	20
these results demonstrate that	20
the primary endpoint was	20
aim of our study	20
of t and b	20
one of the main	20
increased morbidity and mortality	20
had at least one	20
of chronic gvhd was	20
median age at transplantation	20
was peripheral blood in	20
age at hsct was	20
b and nk cells	20
for heart and lung	20
allogenic hematopoietic stem cell	20
study was to compare	20
gvhd was observed in	20
in the presence or	20
in this patient population	20
incidence and severity of	20
no conflicts of interest	20
in the production of	20
in renal transplant patients	20
in patients who had	20
of patients in the	20
autologous stem cell transplant	20
incidence of grade ii	20
a review of the	20
were enrolled in the	20
investigated the role of	20
a reduction in the	20
society for heart and	20
innate and adaptive immune	20
following hematopoietic stem cell	20
international society for heart	20
half of the patients	20
a matched sibling donor	20
cd cells in the	20
age of patients was	20
by the presence of	20
determined by flow cytometry	20
was similar in both	20
in children and adolescents	20
with human immunodeficiency virus	20
a crucial role in	20
in kidney transplant recipients	20
should be considered as	20
have been described in	20
large b cell lymphoma	20
reported in the literature	20
at the onset of	20
stem cell transplantation and	20
patients with hematologic malignancies	20
diseases society of america	20
for each of the	20
not significantly different between	20
the first year post	20
haematopoietic stem cell transplant	20
stem cell transplant patients	19
in the immunocompromised host	19
compared to those with	19
for acute myeloid leukemia	19
more likely to be	19
role in the pathogenesis	19
the use of a	19
for the induction of	19
in of patients with	19
patients were divided into	19
in recipients of allogeneic	19
here we report the	19
the only curative option	19
risk factors associated with	19
influenza a and b	19
followed by autologous stem	19
were found to have	19
is a major cause	19
with no evidence of	19
and risk factors for	19
compared to patients without	19
respiratory syncytial virus infection	19
infants and young children	19
hsct in our center	19
is a frequent complication	19
is to evaluate the	19
received a myeloablative conditioning	19
diffuse large b cell	19
cumulative incidence of acute	19
no difference in the	19
in comparison to the	19
are at risk for	19
a single dose of	19
undergoing allogeneic hematopoietic stem	19
the overall response rate	19
acute and chronic graft	19
has not been reported	19
in the induction of	19
of invasive fungal infections	19
significant difference between the	19
hsct in patients with	19
bone marrow transplantation in	19
at the university hospital	19
can be associated with	19
especially in patients with	19
were not significantly different	19
from an unrelated donor	19
the time of diagnosis	19
than years of age	19
for patients with high	19
pediatric intensive care unit	19
of the t cell	19
increases the risk of	19
infection is associated with	19
and review of the	19
at the moment of	19
time to neutrophil and	19
cell source was peripheral	19
for the use of	19
patients with chronic gvhd	19
patients with haematological malignancies	19
in a single center	19
the national institutes of	19
after the onset of	19
in adult patients with	19
are at increased risk	19
in the intensive care	19
at the last follow	19
a single center experience	19
major cause of morbidity	19
we have previously shown	19
was approved by the	19
airway pressure release ventilation	18
even in the absence	18
principles and practice of	18
the diagnosis of cmv	18
patients who underwent allo	18
matched related or unrelated	18
and mortality after allogeneic	18
from the same donor	18
of invasive fungal infection	18
main cause of death	18
in accordance with the	18
patients with primary immunodeficiency	18
infections after hematopoietic stem	18
patients were diagnosed with	18
grid search over hyperparameters	18
cells in response to	18
were excluded from the	18
pneumonia in patients with	18
of cytomegalovirus disease in	18
the quality of life	18
neutrophil and platelet recovery	18
it has been suggested	18
was used in patients	18
the risk of gvhd	18
was associated with increased	18
the rest of the	18
in patients with multiple	18
patients with aml in	18
incidence and risk factors	18
present the case of	18
infectious diseases working party	18
at the level of	18
the incidence of chronic	18
invasive fungal infections in	18
with respect to the	18
on the presence of	18
did not receive any	18
the united states and	18
to be involved in	18
diagnosis and treatment of	18
european group for blood	18
to the lack of	18
of alloreactive t cells	18
at transplant was years	18
infection in lung transplant	18
by autologous stem cell	18
quality of life and	18
has been used in	18
of gd t cells	18
of the disease and	18
of the most common	18
of graft versus host	18
patients with relapsed refractory	18
increase the risk of	18
neonatal intensive care unit	18
patients undergoing allogeneic hematopoietic	18
in a large cohort	18
the median follow up	18
patients are alive and	18
of acute or chronic	18
was to compare the	18
enrolled in the study	18
the european group for	18
blood and marrow transplant	18
the standard of care	18
a better understanding of	18
the first days of	18
was diagnosed in patients	18
we investigated the role	18
world data with implanted	18
we have developed a	18
our data show that	18
and chronic gvhd were	18
the goal of this	18
respiratory viral infections in	18
associated with increased mortality	18
of the innate immune	18
our data indicate that	18
tacrolimus and mycophenolate mofetil	18
of the use of	18
analyzed by flow cytometry	18
was no difference between	18
the source of stem	18
hematopoetic stem cell transplantation	17
after autologous stem cell	17
to be the most	17
had a history of	17
area under the curve	17
was bone marrow in	17
outcomes in patients with	17
we did not observe	17
age at transplantation was	17
was associated with the	17
patients who had undergone	17
were significantly associated with	17
from diagnosis to transplant	17
in patients who underwent	17
was seen in patients	17
was shown to be	17
a critical role in	17
hematopoietic cell transplant recipients	17
was to determine the	17
to the intensive care	17
he was diagnosed with	17
it is associated with	17
with median age of	17
and platelet engraftment was	17
lower respiratory tract disease	17
a central role in	17
small number of patients	17
the treatment of patients	17
due to the lack	17
is a safe and	17
of modern hopfield networks	17
independent risk factor for	17
with a combination of	17
with the addition of	17
the group of patients	17
in patients with chronic	17
the expression of cd	17
regimen was myeloablative in	17
upper respiratory tract infection	17
in the patients with	17
course was complicated by	17
involved in the pathogenesis	17
he was treated with	17
to evaluate the efficacy	17
and bone marrow transplantation	17
there was no statistically	17
of patients who were	17
did not result in	17
the international society for	17
hematopoietic stem cell transplants	17
is associated with an	17
a significant decrease in	17
fever of unknown origin	17
significant differences between the	17
probability of overall survival	17
a significant difference in	17
occurred in of patients	17
the infectious diseases working	17
independent risk factors for	17
cd t cell responses	17
cells in the graft	17
patients with r r	17
assessed by flow cytometry	17
is the first report	17
as part of a	17
in a lung transplant	17
mhc class i molecules	17
and quality of life	17
was detected in patients	17
prevention of cytomegalovirus disease	17
did not show any	17
and progression free survival	16
the treatment of acute	16
the leading cause of	16
consecutive patients who underwent	16
mg kg day for	16
of donor and recipient	16
who were treated with	16
are needed to confirm	16
in cd t cells	16
included in the analysis	16
majority of patients with	16
cytomegalovirus infection and disease	16
total of patients with	16
with a diagnosis of	16
shown to be effective	16
in the transplant recipient	16
he was found to	16
patients with relapsed or	16
the t cell receptor	16
treatment of choice for	16
we report on a	16
bacterial and fungal infections	16
of acute gvhd was	16
reported to the ebmt	16
should be given to	16
have been identified in	16
was a trend towards	16
to neutrophil engraftment was	16
the first months of	16
received a median of	16
of stem cells was	16
compared to that of	16
in patients who are	16
following allogeneic hematopoietic stem	16
significantly higher in patients	16
be considered in patients	16
neutrophil engraftment was days	16
the activation of the	16
in section a we	16
is due to the	16
no significant differences were	16
of the patients in	16
the entire cohort was	16
test was used to	16
the overall incidence of	16
we report our experience	16
found to have a	16
have previously shown that	16
is believed to be	16
by cd t cells	16
age at time of	16
undergoing allogeneic stem cell	16
for the entire cohort	16
is not associated with	16
as well as for	16
recipients of allogeneic hematopoietic	16
a myeloablative conditioning regimen	16
west nile virus infection	16
switched memory b cells	16
important cause of morbidity	16
incidence of relapse was	16
the incidence and severity	16
in the field of	16
of instances per bag	16
complication of allogeneic hematopoietic	16
overall survival at years	16
all patients received a	16
the vast majority of	16
party of the european	16
occurred at a median	16
of patients were included	16
work was supported by	16
of cd cd cd	16
cmv infection and disease	16
infection and disease in	16
time polymerase chain reaction	16
we show that the	16
receptores de un trasplante	16
are presented in table	16
associated with a lower	16
these findings suggest that	16
of a patient with	16
the nature of the	16
mg kg on day	16
was no statistically significant	16
survival at years was	16
in patients with hematological	16
the characteristics of the	16
a high incidence of	16
interval from diagnosis to	16
graft and patient survival	16
cd t cells with	16
in this group of	16
the patients who received	16
quality of life of	16
of hepatitis c virus	16
the absence of a	16
the efficacy of the	16
for the majority of	16
we did not find	16
we present the case	16
el tratamiento de la	16
of cmv reactivation on	16
this work was supported	16
status at the time	15
be related to the	15
after reduced intensity conditioning	15
a significant increase of	15
transplantation for patients with	15
higher in patients with	15
with a high mortality	15
infections in lung transplant	15
with a high risk	15
no significant differences between	15
aim of the present	15
blood samples were collected	15
does not seem to	15
in a child with	15
due to lack of	15
of cd t cell	15
and chronic gvhd was	15
be due to the	15
gvhd was seen in	15
in the prevention of	15
despite the fact that	15
median of days after	15
is known to be	15
approved for the treatment	15
and there was no	15
used in the treatment	15
diseases working party of	15
rocky mountain spotted fever	15
by flow cytometry using	15
an increased incidence of	15
in the differential diagnosis	15
high index of suspicion	15
patients who received an	15
as a source of	15
between january and june	15
we present a case	15
seems to be a	15
the analysis of the	15
is the treatment of	15
univariate and multivariate analysis	15
it is likely that	15
specific cytotoxic t lymphocytes	15
patients were transplanted from	15
in the atg group	15
and disease free survival	15
the median time between	15
was observed in all	15
to better understand the	15
patients received myeloablative conditioning	15
with relapsed or refractory	15
be associated with a	15
dose chemotherapy followed by	15
in the early phase	15
cell source was bone	15
in the use of	15
there is no consensus	15
the protective effect of	15
at increased risk of	15
from day to day	15
handelt es sich um	15
the infectious diseases society	15
the immune status of	15
systematic review and meta	15
younger than months of	15
were significantly lower in	15
she was started on	15
was detected in of	15
in our cohort of	15
in children younger than	15
the peripheral blood of	15
has not yet been	15
the risk of graft	15
samples were collected from	15
had no impact on	15
mg kg per day	15
up to of patients	15
are at high risk	15
patients with cmv infection	15
with full donor chimerism	15
infections in transplant recipients	15
performed a retrospective analysis	15
has been suggested that	15
data suggest that the	15
the median time for	15
of highly active antiretroviral	15
as an alternative to	15
on the incidence of	15
out of patients with	15
in the control of	15
of patients with acute	15
the first time that	15
were the most common	15
this is a retrospective	15
dose of mg m	15
following allogeneic stem cell	15
lung transplant recipients with	15
has not been established	15
the use of high	15
these data show that	15
of cmv infection and	15
and stem cell transplantation	15
a safe and effective	14
results of a prospective	14
have been used in	14
stem cell transplantation background	14
the basis of the	14
net state of immunosuppression	14
due to the high	14
pediatric lung transplant recipients	14
the outcome of the	14
as soon as possible	14
the quality of the	14
in the activation of	14
it is possible that	14
the treatment of severe	14
of t cells in	14
is shown in figure	14
an increased frequency of	14
cd cell dose was	14
was associated with higher	14
in patients with the	14
related or unrelated donor	14
of herpes simplex virus	14
acquired immunodefi ciency syndrome	14
the use of this	14
with reduction to specific	14
among lung transplant recipients	14
dose chemotherapy and autologous	14
age at diagnosis was	14
for a variety of	14
no significant difference was	14
at last follow up	14
did not respond to	14
number of instances per	14
transmission via breast milk	14
of this retrospective study	14
majority of the patients	14
higher than that of	14
was well tolerated and	14
to reduce the incidence	14
in of the cases	14
been associated with increased	14
of the european group	14
cd t cells was	14
during the period of	14
the time of analysis	14
patients who do not	14
has been demonstrated in	14
an increased risk for	14
has been demonstrated to	14
a period of years	14
year overall survival was	14
the incidence of grade	14
cd t lymphocyte count	14
it was found that	14
has emerged as a	14
are associated with a	14
a longer duration of	14
severe combined immune deficiency	14
hepatitis c virus infection	14
the difference was not	14
and are associated with	14
of lung transplant recipients	14
kommt es zu einer	14
in patients with hematologic	14
the conditioning regimen consisted	14
from a matched sibling	14
on the management of	14
the patients who were	14
cause of death was	14
patient was treated with	14
of expressed breast milk	14
was performed in patients	14
to be an effective	14
our results demonstrate that	14
and the incidence of	14
is a primary immunodeficiency	14
occurred within the first	14
b and t cell	14
appears to be a	14
prophylaxis consisted of cyclosporine	14
in the group with	14
a high level of	14
a retrospective study of	14
of donor t cells	14
a higher rate of	14
a pivotal role in	14
a subset of patients	14
reduces the risk of	14
have a role in	14
the mechanism of action	14
significant risk factor for	14
may be involved in	14
the patients in the	14
infections in immunocompromised patients	14
infection in solid organ	14
are listed in table	14
of the presence of	14
a median time to	14
over hyperparameters with reduction	14
in the expression of	14
were independently associated with	14
can be treated with	14
a heterogeneous group of	14
a result of the	14
median cd cell dose	14
diseases community of practice	14
at time of transplant	14
age at the time	14
with a variety of	14
median time of months	14
the drug of choice	14
in patients with advanced	14
patient died due to	14
involved in the regulation	14
has been described in	14
present study was to	14
for patients with relapsed	14
in order to identify	14
search over hyperparameters with	14
immunosequencing data with implanted	14
the average number of	14
to prevent cytomegalovirus disease	14
years of age and	14
chronic obstructive pulmonary disease	14
hyperparameters with reduction to	14
a lung transplant recipient	14
did not reach statistical	14
to declare p abstract	14
the cause of death	14
of total body irradiation	14
cytomegalovirus in solid organ	14
it is unclear whether	14
are a number of	14
patients at high risk	14
is involved in the	14
from january to december	14
acute gvhd occurred in	14
in our center from	14
in the last decade	14
performed according to the	14
the age of months	14
group of patients with	14
characteristics are shown in	14
on the cell surface	14
and lower respiratory tract	14
are associated with the	14
time to neutrophil recovery	14
at the university of	14
on the surface of	14
of allogeneic hematopoietic cell	14
analysis was performed using	14
safe and effective in	14
on the development of	14
or a combination of	14
incidence of acute and	14
after a median time	14
associated with a significant	14
to be due to	14
important to note that	14
there are a number	14
results of this study	14
of the international society	14
the study is to	14
by the infectious diseases	14
the results of this	14
at the start of	14
factors for the development	14
and chronic gvhd in	14
as a risk factor	14
outcomes of patients with	14
it has been reported	14
to the type of	14
hepatitis b and c	13
in neutropenic patients with	13
should be considered for	13
the end of treatment	13
the risk for transmission	13
we retrospectively analyzed patients	13
society for blood and	13
out of the patients	13
in patients after allogeneic	13
of a variety of	13
of acute graft versus	13
a lower incidence of	13
one or more of	13
in the diagnosis and	13
the clinical manifestations of	13
donor cd t cells	13
median number of cd	13
shown in the table	13
nothing to declare o	13
b and t cells	13
are more likely to	13
disease in solid organ	13
the prevention and treatment	13
en el trasplante de	13
and practice of infectious	13
pediatric hematopoietic stem cell	13
and the duration of	13
for the patients with	13
cell transplantation is the	13
the severity of the	13
play a key role	13
in patients with cmv	13
of allergy and infectious	13
the risk of cmv	13
innate and adaptive immunity	13
autologous haematopoietic stem cell	13
in this cohort of	13
is based on the	13
are at risk of	13
time to platelet engraftment	13
or more of the	13
patient was started on	13
role in the development	13
the most frequent cause	13
survival and overall survival	13
pure red cell aplasia	13
and of the patients	13
kg kg tag in	13
with severe acute respiratory	13
due to disease progression	13
in patients with pid	13
mobilized peripheral blood stem	13
not been reported in	13
is considered to be	13
in a prospective study	13
measured by flow cytometry	13
during the first month	13
better understanding of the	13
t cell activation and	13
patients with or without	13
entre el y el	13
which is associated with	13
cells in peripheral blood	13
a prospective study of	13
only curative option for	13
goal of this study	13
standard of care for	13
as compared to patients	13
samples from patients with	13
a high index of	13
course of the disease	13
lower respiratory tract infection	13
prospective studies are needed	13
of t cell receptor	13
both acute and chronic	13
transmission of hepatitis c	13
were not associated with	13
t cell receptor excision	13
cell receptor excision circles	13
with common variable immunodeficiency	13
and in patients with	13
patients after allogeneic stem	13
characteristics of the patients	13
risk of graft failure	13
extensive chronic gvhd was	13
can be considered as	13
expression of cd and	13
all patients were treated	13
committee on infectious diseases	13
to the pathogenesis of	13
acute and chronic rejection	13
to months after transplantation	13
is the most frequent	13
in den letzten jahren	13
and stem cell transplant	13
in the proportion of	13
transplant related mortality was	13
with the aim to	13
were not statistically significant	13
for pneumocystis carinii pneumonia	13
all patients had received	13
was higher in the	13
in patients with human	13
with a higher risk	13
mg m on day	13
here we show that	13
considered in patients with	13
of nkg d ligands	13
a small number of	13
patients who underwent hsct	13
upper and lower respiratory	13
streptococcal toxic shock syndrome	13
year os and pfs	13
similar to that of	13
clinical practice guideline for	13
present a case of	13
the clinical significance of	13
significant proportion of patients	13
was found in the	13
first year of life	13
very good partial response	13
of solid organ transplant	13
significant increase in the	13
in high risk patients	13
was used to compare	13
when compared to the	13
the intensity of the	13
chez les patients sida	13
adult lung transplant recipients	13
was more common in	13
a history of recurrent	13
on the type of	13
an independent risk factor	13
m r and b	13
and extensive chronic gvhd	13
the median dose of	13
significant differences were observed	13
cells and nk cells	13
of peripheral blood stem	13
in the renal transplant	13
there was no statistical	13
who did not develop	13
and is characterized by	13
of patients at risk	13
recipients of hematopoietic stem	13
from matched unrelated donors	13
of the lack of	13
the mean number of	13
an effective treatment for	13
to be able to	13
he was started on	13
of the patients developed	13
in order to reduce	13
is an effective treatment	13
also been associated with	13
of the most important	13
not reach statistical significance	13
our data demonstrate that	13
of t cell activation	13
related or unrelated donors	13
lower respiratory tract infections	13
to play a role	13
compared to the control	13
aim of this retrospective	13
of west nile virus	13
in a number of	13
associated with a longer	13
unrelated umbilical cord blood	13
more than of the	13
it is not clear	12
of the development of	12
risk acute myeloid leukemia	12
of stem cells in	12
en el caso del	12
report the results of	12
infections in solid organ	12
cumulative incidence of agvhd	12
at time of transplantation	12
were transplanted in cr	12
of hepatitis b virus	12
signs and symptoms of	12
data indicate that the	12
is a severe complication	12
that the presence of	12
hematopoietic stem cells transplantation	12
may be able to	12
increase in the number	12
of cmv reactivation in	12
of hla class i	12
may be related to	12
allergy and infectious diseases	12
with reduced intensity conditioning	12
be as high as	12
who underwent allogeneic hematopoietic	12
between and were included	12
as well as other	12
blood stem cells were	12
to the use of	12
a decrease in the	12
from the time of	12
the authors declare no	12
the area under the	12
who did not have	12
a negative impact on	12
the acute phase of	12
to be related to	12
differences were observed in	12
been reported in the	12
part of the conditioning	12
infection in renal transplant	12
in lung transplant patients	12
one of the two	12
evaluate the safety and	12
morbidity and mortality of	12
in sot and hsct	12
patients who had received	12
to evaluate the safety	12
has been described as	12
was seen in of	12
the acquired immunodefi ciency	12
can be found in	12
the prognostic impact of	12
with hematopoietic stem cell	12
reduced intensity conditioning regimens	12
related morbidity and mortality	12
disease at time of	12
a wide variety of	12
received stem cells from	12
considered in the differential	12
therapy and prophylaxis of	12
is essential for the	12
a graft from a	12
the first months post	12
in the generation of	12
we report the results	12
associated with increased morbidity	12
that can lead to	12
t cell proliferation and	12
a significant risk factor	12
cd cells per kg	12
been associated with a	12
decrease the risk of	12
that the incidence of	12
to determine whether the	12
of the role of	12
was no statistical difference	12
for the generation of	12
of acute myeloid leukemia	12
the duration of neutropenia	12
alive and disease free	12
were significantly higher than	12
in line with the	12
to years of age	12
have nothing to disclose	12
in the range of	12
for at least days	12
given in table a	12
von mensch zu mensch	12
autologous hematopoietic cell transplantation	12
is a rare but	12
cd t lymphocyte counts	12
of cd cells infused	12
that there is a	12
after allogeneic haematopoietic stem	12
who underwent allogeneic hsct	12
the present study we	12
be considered as an	12
be explained by the	12
treatment option for patients	12
risk of cmv reactivation	12
and were included in	12
viral infections of the	12
a total of pts	12
have been treated with	12
was found in patients	12
of patients with primary	12
patients at risk of	12
of pneumocystis carinii pneumonia	12
the immune response to	12
associated with development of	12
incidence of cmv disease	12
has been used to	12
bone marrow transplantation unit	12
patients were conditioned with	12
infection has been reported	12
in all patients with	12
in adults and children	12
underwent allogeneic hematopoietic stem	12
the first report of	12
of infused cd cells	12
the overall survival was	12
can be caused by	12
were measured by elisa	12
did not correlate with	12
the treatment of cmv	12
the polymerase chain reaction	12
the results of a	12
in the evaluation of	12
investigate the impact of	12
allogeneic bone marrow transplant	12
the results of our	12
after the end of	12
the presence of cmv	12
the onset of the	12
upper respiratory tract infections	12
significantly lower in the	12
solid organ transplant patients	12
most common causes of	12
we have previously reported	12
is more likely to	12
mg kg on days	12
here we report our	12
on the th day	12
on cd t cells	12
and one patient had	12
of infection in the	12
did not influence the	12
the ebmt risk score	12
mortality in patients with	12
acute renal failure in	12
in peripheral blood mononuclear	12
in a subset of	12
the performance of the	12
regimens were used in	12
the absence of the	12
informed consent was obtained	12
in patients with relapsed	12
no statistically significant differences	12
can be divided into	12
free survival and overall	12
these data demonstrate that	12
and bone marrow in	12
first year after transplantation	12
acute gvhd of the	12
is caused by a	12
the absence of any	12
were randomized to receive	12
for a number of	12
by the addition of	12
as well as to	12
of these patients were	12
the patients who had	12
is a major complication	12
and event free survival	12
institute of allergy and	12
at our institution between	12
study was designed to	12
practice of infectious diseases	12
in kidney transplant patients	12
the predictive value of	12
a major role in	12
both in vitro and	12
and the effect of	12
was used in of	12
was independently associated with	12
associated with a reduced	12
hsct in children with	12
the cumulative incidences of	12
and risk factors of	12
national institute of allergy	12
no differences in the	12
patients developed acute gvhd	12
with human immunodefi ciency	12
cd t cells to	12
with severe aplastic anemia	12
blood stem cell transplant	12
children and adolescents with	12
patients at risk for	12
mammalian target of rapamycin	12
patients received bone marrow	12
are alive and disease	12
of solid organ transplantation	12
transmission of human t	12
the most common causes	12
in a series of	12
in the face of	12
has not been previously	12
it is difficult to	12
of extensive chronic gvhd	12
safe and well tolerated	12
for patients with refractory	12
of cytomegalovirus infection in	12
is associated with higher	12
of cytomegalovirus infection and	12
significantly higher than that	12
plays a crucial role	12
effect of cmv reactivation	12
a significant cause of	12
is an important cause	12
hematopoietic stem cell transplantations	12
in vivo and in	12
included in this analysis	12
is shown in table	12
by mutations in the	12
for at least months	12
higher in patients who	12
a trend for a	12
our findings suggest that	12
in children with severe	12
in of patients and	12
and the need for	12
is safe and effective	12
was performed in the	12
an overview of the	12
with autologous stem cell	12
is likely to be	12
foxp regulatory t cells	12
and no evidence of	12
number of patients with	12
are alive and well	12
history was significant for	12
for allogeneic stem cell	12
and all of them	11
specific t cells from	11
kg of body weight	11
sensitivity and specificity of	11
conditioning regimens were used	11
is the first study	11
determine the role of	11
as the use of	11
that can be used	11
significantly lower in patients	11
is characterized by a	11
diseases and the kidney	11
have an impact on	11
difference was not statistically	11
acute gvhd was observed	11
the absence of an	11
significant difference was found	11
main causes of death	11
the causes of death	11
a common cause of	11
of the cases of	11
consent was obtained from	11
here we report on	11
variants of uncertain significance	11
of invasive pulmonary aspergillosis	11
with an incidence of	11
with higher risk of	11
patients with mds and	11
cells in the peripheral	11
the world health organization	11
kg tag in ed	11
evaluate the effect of	11
study was to identify	11
were shown to be	11
one patient died due	11
of the disease is	11
were similar in both	11
la intensidad de la	11
and mortality in patients	11
adverse events were reported	11
and reduced intensity conditioning	11
has been identified in	11
the first years after	11
treatment in patients with	11
may be considered as	11
myeloablative allogeneic stem cell	11
to platelet engraftment was	11
the causative agent of	11
a group of patients	11
are the most frequent	11
retrospective analysis of patients	11
in patients who developed	11
patients with cystic fibrosis	11
associated with higher risk	11
patients with a history	11
this is the largest	11
cellular and humoral immunity	11
should be noted that	11
vertical transmission of hepatitis	11
retrospective study was to	11
between and at our	11
and in some cases	11
has been implicated in	11
shown to be associated	11
increase the number of	11
it is known that	11
allogeneic peripheral blood stem	11
the pediatric intensive care	11
haploidentical bone marrow transplantation	11
at the site of	11
were compared using the	11
a retrospective review of	11
median duration of follow	11
investigated the impact of	11
the incidence of agvhd	11
has also been described	11
transplant recipients are at	11
fi rst complete remission	11
by polymerase chain reaction	11
analysis was performed with	11
the morbidity and mortality	11
found to be a	11
infections in the immunocompromised	11
is more common in	11
the mean age was	11
from a matched related	11
characteristics are summarized in	11
management of patients with	11
in adult lung transplant	11
significant differences in the	11
specific t cells were	11
for prevention of cytomegalovirus	11
a high mortality rate	11
with the diagnosis of	11
de la enfermedad por	11
of this study were	11
chemotherapy followed by autologous	11
divided into two groups	11
has received honoraria from	11
analyses were performed using	11
advisory committee on immunization	11
after hematopoietic cell transplantation	11
not significantly associated with	11
there is a significant	11
were associated with higher	11
be safe and effective	11
for the diagnosis and	11
we could show that	11
we would like to	11
university school of medicine	11
an allogeneic stem cell	11
among the patients with	11
the duration of the	11
is a potentially curative	11
and platelet engraftment were	11
more than half of	11
vivo t cell depletion	11
the second most common	11
the renal transplant recipient	11
probably due to the	11
inborn errors of immunity	11
infectious diseases and the	11
taking into account the	11
in order to determine	11
end of the first	11
over years of age	11
was observed in of	11
granulocyte colony stimulating factor	11
a high number of	11
overall response rate was	11
status of the patient	11
of the virus in	11
this study aimed to	11
the acquired immunodeficiency syndrome	11
we retrospectively reviewed the	11
was performed using the	11
our institution between and	11
the diagnosis of invasive	11
patients undergoing allogeneic stem	11
patients did not receive	11
in terms of os	11
to the degree of	11
was higher in patients	11
a year old male	11
during the fi rst	11
were observed in patients	11
conditioning regimen followed by	11
a short course of	11
gvhd of the skin	11
the impact of donor	11
the first dose of	11
are shown in figure	11
the patient and the	11
it is well known	11
clinically significant cmv infection	11
the regulation of the	11
in the plerixafor group	11
median dose of cd	11
and graft versus host	11
patients with acute gvhd	11
for a minimum of	11
t cells from the	11
all but one patient	11
studies are required to	11
showed a trend towards	11
analysis was performed by	11
of adult patients with	11
are given in table	11
disease as well as	11
a larger number of	11
committee on immunization practices	11
received a transplant from	11
es sich um eine	11
we observed that the	11
tumor necrosis factor alpha	11
phase of the disease	11
it should be noted	11
and acute renal failure	11
in the conditioning regimen	11
here we report a	11
the diagnosis is made	11
a wide array of	11
de enfermedad por cmv	11
this cohort of patients	11
mg m on days	11
patients included in the	11
free and overall survival	11
as a part of	11
were observed in the	11
reported in patients with	11
infectious diseases community of	11
are similar to those	11
is important to note	11
iv acute gvhd and	11
the most important risk	11
our cohort of patients	11
patients were in complete	11
child transmission of human	11
and the absence of	11
were males and females	11
the start of the	11
american academy of pediatrics	11
for a period of	11
between january and november	11
should be suspected in	11
a low incidence of	11
european society for blood	11
authors have nothing to	11
were performed in patients	11
a statistically significant difference	11
and were treated with	11
cd t cells by	11
in order to evaluate	11
and was associated with	11
is an autosomal recessive	11
mortality after allogeneic hematopoietic	11
have the ability to	11
were not able to	11
a total dose of	11
with the risk of	11
was given to patients	11
was achieved in of	11
in the t cell	11
survival of patients with	11
patients who received hsct	11
with acute lymphoblastic leukemia	11
the first day of	11
the incidence of gvhd	11
a case of a	11
for patients with aml	11
fludarabine mg m day	11
as shown in table	11
overall survival rate was	11
the presence of donor	11
p abstract already published	11
in comparison with the	11
cells from healthy donors	11
and disease status at	11
r and b r	11
at the dose of	11
prevention of cmv infection	11
patients who were diagnosed	11
is characterized by the	11
been shown to have	11
large cohort of patients	11
at the beginning of	11
and the impact of	11
enzyme linked immunosorbent assay	11
of the patients and	11
from peripheral blood of	11
was not different between	11
of neutrophil and platelet	11
plays a role in	11
reduced the incidence of	11
with increased morbidity and	11
did not differ significantly	11
most frequent cause of	11
of the entire cohort	11
with acquired immunodeficiency syndrome	11
no serious adverse events	11
the immune system and	11
there are reports of	11
herpes simplex virus type	11
prior to transplant and	11
of cd cd t	11
in group a and	11
are among the most	11
before the onset of	11
patients with severe aplastic	11
iv and grade iii	11
balb c mice were	11
follow up was months	11
relapse or progression of	11
kg day for days	11
cells were isolated from	11
median time of neutrophil	11
case report and review	11
highlights the importance of	11
cd foxp regulatory t	11
gd t cells in	11
at the cell surface	11
to the risk of	11
leading cause of death	11
or peripheral blood stem	11
and should be considered	11
patients who had a	11
in the outcome of	11
a positive correlation between	11
in the posttransplant period	11
the high incidence of	11
in hematopoietic cell transplant	11
t cells specific for	10
of t cells with	10
ptcy as gvhd prophylaxis	10
to a lesser extent	10
patients transplanted in cr	10
related quality of life	10
between donor and recipient	10
curative therapy for patients	10
as well as of	10
in patients with acquired	10
of renal transplant recipients	10
curl new delhi virus	10
show for the first	10
in the patient with	10
patients who were treated	10
the development of agvhd	10
the importance of the	10
prognosis of patients with	10
to determine the role	10
therapeutic option for patients	10
prophylaxis and treatment of	10
is a paucity of	10
and a review of	10
the development of chronic	10
were significantly increased in	10
we hypothesized that the	10
the main causes of	10
method was used to	10
were performed according to	10
cytomegalovirus disease in solid	10
patients received a myeloablative	10
in patients with and	10
is often associated with	10
reactivation was associated with	10
chemotherapy and autologous stem	10
improve the outcome of	10
is required for the	10
described in the literature	10
dose chemotherapy with autologous	10
be used to treat	10
was also observed in	10
the use of anti	10
to months of age	10
chronic gvhd occurred in	10
as a marker for	10
as graft versus host	10
of the current study	10
for prevention and treatment	10
and human herpes virus	10
that are associated with	10
activated cd t cells	10
the assessment of the	10
analysis was performed to	10
tomato leaf curl new	10
cd cd bright foxp	10
is also associated with	10
the first days post	10
and has been associated	10
food and drug administration	10
as a bridge to	10
there is no specific	10
stem cell transplantation as	10
graft failure was observed	10
regimen was used in	10
cell leukemia virus type	10
the clinical diagnosis of	10
all of the patients	10
percent of the patients	10
was assessed by flow	10
a high proportion of	10
was carried out with	10
not associated with increased	10
plays a central role	10
as high as to	10
the frequency of the	10
report of the committee	10
a rare autosomal recessive	10
reported to be effective	10
is no consensus on	10
over the last decades	10
patients with cancer and	10
of patients had a	10
of patients were in	10
bone marrow and peripheral	10
the management of cytomegalovirus	10
and cord blood in	10
en los casos de	10
in the blood of	10
quantitative polymerase chain reaction	10
stem cell source in	10
for patients with acute	10
stem cell transplantation recipients	10
of relapse or progression	10
to be a major	10
bone marrow transplantation for	10
one of the patients	10
further studies are required	10
the differential diagnosis of	10
study was supported by	10
to evaluate the incidence	10
the presence of hla	10
t cells have been	10
from the day of	10
was used to assess	10
the number of sequences	10
as a marker of	10
prevention and management of	10
according to the type	10
was carried out by	10
confirmed the presence of	10
the production of il	10
cd cd cd cd	10
at various time points	10
we have analyzed the	10
in vivo t cell	10
with hiv infection and	10
samples were collected at	10
of relapse at years	10
we previously showed that	10
x kg cd cells	10
the conditioning regimen and	10
et al reported on	10
undergoing bone marrow transplantation	10
can be used for	10
es besteht keine meldepflicht	10
was more frequent in	10
by emerson et al	10
newborn screening for scid	10
infection after allogeneic stem	10
t and nk cells	10
of the cd t	10
in the pediatric population	10
as compared to control	10
patients were followed for	10
the patient had a	10
known to be associated	10
of the underlying disease	10
without the need for	10
needed to confirm these	10
was the only factor	10
versus host disease in	10
excluded from the analysis	10
with chronic granulomatous disease	10
received a reduced intensity	10
critical role in the	10
at a single center	10
in the first month	10
stem cell sources were	10
nk cells in the	10
in a median of	10
a wide spectrum of	10
vivo and in vitro	10
in a group of	10
can also be used	10
is a common complication	10
significantly associated with the	10
it was observed that	10
the clinical course of	10
related and unrelated donors	10
these results indicate that	10
before and after the	10
a trend towards a	10
significantly different between the	10
alive at a median	10
received reduced intensity conditioning	10
of activated t cells	10
the clinical features of	10
seen in patients with	10
have been identified as	10
activation and proliferation of	10
t cells with a	10
for all patients was	10
our understanding of the	10
patient was diagnosed with	10
well tolerated with no	10
the primary endpoint of	10
source was pb in	10
was added to the	10
the registry of the	10
that they have no	10
did not lead to	10
were found in patients	10
to determine the incidence	10
who did not receive	10
with an average auc	10
to evaluate the effect	10
and for patients with	10
be associated with an	10
infections in renal transplant	10
patients at a median	10
high dose chemotherapy followed	10
curative option for patients	10
patients were transplanted for	10
a higher percentage of	10
with high levels of	10
at least in part	10
the possible role of	10
play a critical role	10
to test the hypothesis	10
were adoptively transferred into	10
for hematopoietic cell transplantation	10
was used to identify	10
an integral part of	10
leaf curl new delhi	10
cd ra and cd	10
in a dose dependent	10
stem cell source and	10
the outcome of allogeneic	10
differences between the two	10
in patients transplanted from	10
has not been well	10
viral and fungal infections	10
adverse events related to	10
conditioning regimen consisting of	10
during the first years	10
os and pfs were	10
incidence and outcome of	10
in complete remission and	10
in a heart transplant	10
was supported by the	10
from the peripheral blood	10
was considered statistically significant	10
the innate and adaptive	10
observed in patients with	10
of the lower respiratory	10
the committee on infectious	10
donor was unrelated in	10
the first time in	10
evaluated by flow cytometry	10
the net state of	10
marrow and peripheral blood	10
has been found in	10
median number of previous	10
median time to relapse	10
the length of the	10
it was shown that	10
cells were transfected with	10
patients are alive with	10
than or equal to	10
in cd and cd	10
the patient was started	10
was significantly lower than	10
the conditioning regimen for	10
on the role of	10
infections in recipients of	10
blood was used as	10
in our center between	10
although the number of	10
in patients undergoing hsct	10
and the role of	10
in order to investigate	10
the transplant related mortality	10
a randomized clinical trial	10
to an increase in	10
may lead to the	10
a leading cause of	10
used for gvhd prophylaxis	10
nothing to declare methods	10
patients were in cr	10
with severe combined immunodeficiency	10
in response to the	10
not differ between the	10
is usually associated with	10
can be detected in	10
in the univariate analysis	10
of allogeneic bone marrow	10
is a member of	10
the primary outcome was	10
patients who underwent haplo	10
showed a significant increase	10
an average auc of	10
this study we have	10
risk for transmission of	10
the early phase of	10
conflicts of interest to	10
been described in the	10
the large number of	10
there is a paucity	10
could be used as	10
in a model of	10
the patient was treated	10
of the patients are	10
intensity of the conditioning	10
common cause of death	10
and the lack of	10
were more frequent in	10
this was associated with	10
for a total of	10
of the committee on	10
a standard of care	10
and the occurrence of	10
cd and cd cd	10
and the median time	10
investigated the effect of	10
important risk factor for	10
the management of these	10
studies are warranted to	10
were the most frequent	10
on the same day	10
we report the first	10
the mean grayscale value	10
risk factor for the	10
have been performed in	10
following bone marrow transplantation	10
the full hyperparameter search	10
and herpes simplex virus	10
in patients who were	10
the use of g	10
we performed a prospective	10
was also associated with	10
adult patients with acute	10
the potential role of	10
after haematopoietic stem cell	10
key role in the	10
is a rare autosomal	10
mean grayscale value of	10
a high prevalence of	10
differences between the groups	10
the hyperparameter search of	10
the percentage of patients	10
was found in of	10
we sought to determine	10
herpes simplex virus in	10
is associated with high	10
mg kg day i	10
are known to be	10
isolated from peripheral blood	10
this study demonstrates that	10
include the use of	10
unrelated cord blood transplantation	10
with the introduction of	10
of patients with hiv	10
use of high dose	10
cmv dna load in	10
we found a significant	10
resulted in a significant	10
for immune repertoire classification	10
cause of treatment failure	10
were obtained from the	10
a systematic review and	10
received myeloablative conditioning regimen	10
the incidence of infections	10
as the cause of	10
with high morbidity and	10
was also found to	10
play a pivotal role	10
in patients suffering from	10
fungal infections in patients	10
of viral infections in	10
bone marrow failure syndromes	10
compound heterozygous mutations in	10
in order to establish	10
followed by autologous hematopoietic	10
in this patient cohort	10
in the rate of	10
patients who received allo	10
and may be a	10
were associated with increased	10
an independent predictor of	10
ex vivo expansion of	10
here we present a	10
evaluate the efficacy of	10
major cause of death	10
prophylaxis was performed with	10
of umbilical cord blood	10
was successfully treated with	10
the progression of the	10
in patients with non	10
may serve as a	10
to allogeneic stem cell	10
for bronchiolitis obliterans syndrome	10
t cell development and	10
and chronic graft versus	10
deaths were due to	10
los receptores de un	10
is part of the	10
the prevention of cytomegalovirus	9
conditioning was used in	9
all patients were transplanted	9
report a case of	9
is a rare disease	9
the feasibility and safety	9
graft vs host disease	9
alive with a median	9
objective of the study	9
the first years of	9
in patients with mm	9
she was treated with	9
specific cd t cell	9
is the most commonly	9
mg kg body weight	9
been demonstrated to be	9
transplant recipients in the	9
median follow up time	9
and heart transplant recipients	9
as shown in the	9
in a renal transplant	9
hepatitis b surface antigen	9
of b cells and	9
peripheral blood samples were	9
are associated with an	9
on the expression of	9
of stem cell transplantation	9
gvhd occurred in patients	9
characteristics and outcomes of	9
was started at a	9
through the use of	9
in the frequency of	9
in patients with low	9
have been linked to	9
for patients with severe	9
remission at the time	9
was not detected in	9
cd cells on day	9
first months after transplantation	9
of bronchiolitis obliterans syndrome	9
central role in the	9
the lack of a	9
registry of the international	9
at our center between	9
renal transplant recipients with	9
in paediatric patients with	9
for more than days	9
overall survival in patients	9
compared with patients without	9
in this patient group	9
of patients with high	9
in most of the	9
diarrhea in hiv patients	9
at least one episode	9
class i and ii	9
patients with acute respiratory	9
cd t cell response	9
similar results were obtained	9
in view of the	9
from the bone marrow	9
samples were obtained from	9
in our institution between	9
t and b lymphocytes	9
a treatment option for	9
the use of plerixafor	9
of cd cells on	9
infections as well as	9
fever with renal syndrome	9
months of age with	9
infections after lung transplantation	9
serum levels of il	9
stem cell transplantation after	9
full donor chimerism was	9
our study is to	9
we have investigated the	9
peripheral blood progenitor cells	9
with herpes simplex virus	9
b cells in the	9
by a variety of	9
with sickle cell disease	9
hsct levels at months	9
a retrospective cohort study	9
relapse at years was	9
infections after allogeneic hematopoietic	9
under the control of	9
no differences were observed	9
patients with newly diagnosed	9
has been identified as	9
more than of patients	9
test the hypothesis that	9
aids clinical trials group	9
staphylococcal toxic shock syndrome	9
guidelines on the management	9
the outcomes of patients	9
of patients who had	9
of the cmv promoter	9
are likely to be	9
further studies are warranted	9
is a rare complication	9
the mean age at	9
up for survivors was	9
who received hsct from	9
a patient with a	9
did not differ in	9
in elderly patients with	9
for more than months	9
was based on the	9
risk factors and outcomes	9
platelet engraftment was days	9
cd bright foxp t	9
early in the course	9
to the ebmt registry	9
para el tratamiento de	9
study was to analyse	9
who do not have	9
infused cd cell dose	9
in patients with agvhd	9
cyclosporine and mycophenolate mofetil	9
length of stay in	9
an hla identical sibling	9
in patients who have	9
bright foxp t cells	9
patients developed chronic gvhd	9
the gold standard for	9
in patients with cgvhd	9
the development of the	9
this study aims to	9
infections in hematopoietic stem	9
lower in patients with	9
study is to determine	9
to be a significant	9
of this analysis was	9
the best of our	9
the first and second	9
of patients with cmv	9
vgamma vdelta t cells	9
group compared to the	9
bone marrow biopsy was	9
specific t cell responses	9